The article presents Inclusion by Design as a management plan for auditable representation across clinical trials and data infrastructures[1]. The aim is to embed the principles of equality, diversity and inclusion (EDI) into the governance of clinical research within the NHS and its research infrastructure[1]. The World Health Organization (WHO) identified this topic as a global priority at the recent Clinical Trials Summit, with an emphasis on improving community engagement and removing barriers for underrepresented populations[1]. At the King's Clinical Research Facility (CRF) at King's College Hospital in London, strategies for Patient and Public Involvement (PPI) and EDI[1] were created in March 2023. The EDI working group was established in November 2023 and consists of five diverse public contributors, two EDI employees from KCH and two coordinators from CRF[1]. Training materials for staff were co-created with PPI members using the co-production method, which includes shared input, balance of power and joint decision-making[1]. These approaches address underrepresentation in clinical trials and the need for diverse research staff and participants[1].